GOLDMAN SACHS GROUP INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,459
-90.2%
16,291
-83.1%
0.00%
Q2 2023$239,329
+45.7%
96,116
+56.8%
0.00%
Q1 2023$164,257
-88.7%
61,290
-77.1%
0.00%
Q4 2022$1,454,274
-64.9%
267,822
-19.3%
0.00%
-100.0%
Q3 2022$4,144,000
+146.7%
331,830
-2.4%
0.00%
Q2 2022$1,680,000
-50.3%
340,034
-23.6%
0.00%
-100.0%
Q1 2022$3,383,000
-13.7%
445,137
+15.9%
0.00%0.0%
Q4 2021$3,920,000
-57.5%
383,952
-44.2%
0.00%
-50.0%
Q3 2021$9,229,000
-5.1%
687,704
+55.1%
0.00%0.0%
Q2 2021$9,725,000
-29.3%
443,259
-22.5%
0.00%
-33.3%
Q1 2021$13,758,000
-18.6%
571,795
-39.1%
0.00%
-25.0%
Q4 2020$16,902,000
+53.1%
939,561
-1.7%
0.00%
+33.3%
Q3 2020$11,042,000
+81.0%
956,001
+280.1%
0.00%
+50.0%
Q2 2020$6,102,000
+167.2%
251,515
+21.3%
0.00%
+100.0%
Q1 2020$2,284,000
-50.3%
207,278
+19.3%
0.00%0.0%
Q4 2019$4,592,000
-21.8%
173,752
-32.6%
0.00%
-50.0%
Q3 2019$5,870,000
+53.4%
257,692
+106.5%
0.00%
+100.0%
Q2 2019$3,826,000
+100.3%
124,799
+8.5%
0.00%0.0%
Q1 2019$1,910,000
+11.5%
115,053
+28.6%
0.00%0.0%
Q4 2018$1,713,000
-63.7%
89,468
-0.8%
0.00%0.0%
Q3 2018$4,715,000
+180.0%
90,173
+132.8%
0.00%
Q2 2018$1,684,000
+124.5%
38,741
+91.4%
0.00%
Q1 2018$750,000
+33.5%
20,242
-28.5%
0.00%
Q4 2017$562,000
+168.9%
28,308
+237.6%
0.00%
Q3 2017$209,000
-81.7%
8,385
-87.2%
0.00%
Q2 2017$1,144,00065,5750.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders